The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories
Issuer Directory


< Previous Page
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
Next Page >

Bimini Capital Management, Inc. invests primarily in, but is not limited to, residential mortgage-related securities issued by the Federal National Mortgage Association (Fannie Mae), the Federal Home Loan Mortgage Corporation (Freddie Mac) and the Government National Mortgage Association (Ginnie Mae). ...

View Profile

BIND Therapeutics is a clinical-stage nanomedicine company developing a pipeline of ACCURINS®, its novel targeted therapeutics designed to increase the concentration and duration of therapeutic payloads at disease sites while reducing exposure to healthy tissue. BIND is leveraging its Medicinal ...

View Profile

BioBlast Pharma is a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. The company is rapidly building a diverse portfolio of product candidates with the potential to address unmet medical needs for ...

View Profile

BIO-key International is a leading provider of fingerprint biometric identification, secure mobile credentialing and user identity verification solutions. We help customers reduce risk, protect and enhance the value of their services and assets, while minimizing the ongoing costs for Access Control and ...

View Profile

Bio-Path is a biotechnology company focused on developing therapeutic products utilizing DNAbilize™, its liposomal and proprietary antisense delivery technology, to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous transfusion. Bio-Path’s lead ...

View Profile

BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various chemical market customers in the United States. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into chemicals that are ...

View Profile

BASi is a pharmaceutical development company providing contract research services and monitoring instruments to the world's leading drug development companies and medical research organizations. BASi focuses on developing innovative services and products that increase efficiency and reduce the cost ...

View Profile

biOasis Technologies Inc. (TSX-V:BTI) is a publically traded biopharmaceutical company focused on developing and commercializing proprietary pharmaceutical products and diagnostic technologies for central nervous system ("CNS") diseases and disorders. Of particular interest is the creation of ...

View Profile

biOasis Technologies Inc. (TSX-V:BTI) is a publically traded biopharmaceutical company focused on developing and commercializing proprietary pharmaceutical products and diagnostic technologies for central nervous system ("CNS") diseases and disorders. Of particular interest is the creation of ...

View Profile

Founded in 2006, BioCEP Ltd., a privately owned, Israeli company is focused on the development of cutting-edge technologies for cell isolation. BioCEP develops, manufactures and sells these products to its customers, worldwide. Its patented Cell Enrichment Process is incorporated in the CEPir (Cell ...

View Profile

Biocept, Inc., a cancer diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA tests utilizing a standard blood sample. The company’s tests provide information to oncologists that enable them to select the appropriate treatment for their ...

View Profile

BioCorRx, Inc. ® is a healthcare solutions development company on the leading edge of addiction treatment programs. The company currently owns an addiction treatment program called the Start Fresh Program ® (SFP) that is used by various independently owned licensed addiction clinics ...

View Profile

Biodel Inc., a specialty biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes in the United States. Its lead product candidate is a glucagon emergency management (GEM) device that is intended to treat diabetes patients experiencing severe hypoglycemia, ...

View Profile

BioLargo’s business strategy is to harness and deliver Nature’s Best Solution® — free-iodine — in a safe, efficient, environmentally sensitive and cost-effective manner. BioLargo’s proprietary technology works by combining micro-nutrient salts with liquid from any ...

View Profile

BIOLASE is revolutionizing surgery in dentistry and medicine with WaterLase technology. The company specializes in the development, manufacturing and marketing of lasers and related products to provide biological treatments that eliminate pain and are safer for patients. BIOLASE leads the global dental ...

View Profile

BioLife Solutions, Inc. develops, manufactures, and markets patented hypothermic storage and cryopreservation solutions for cells and tissues in the United States. The company’s products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, delayed-onset cell ...

View Profile

BioLight Life Sciences Investments Ltd. invests in, manages and commercializes biomedical innovations grouped into “clusters” around defined medical conditions. The two current clusters are in ophthalmology via 100% ownership of XLVision Sciences, and in cancer diagnostics via a 31% ...

View Profile

BioLineRx Ltd., a clinical stage biopharmaceutical development company, engages in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs. The company’s development pipeline consists of clinical-stage therapeutic candidates, including BL-1040, a novel polymer ...

View Profile

BioMark Diagnostics is developing proprietary, non-invasive, and accurate cancer diagnostic solutions, which can help detect, monitor and assess treatment for cancer early and cost effectively. The technology can also be used for measuring response to treatment and potentially for serial monitoring for ...

View Profile

BioMarker Strategies is a tissue-based cancer diagnostics company that is developing the SnapPath® live tumor cell testing platform* to improve the treatment of ...

View Profile

Biomay aspires to be a worldwide leader in research, discovery and development of disease modifying allergy therapeutics. Biomay's products will dramatically improve the quality of life of patients by offering long-term cure for their ...

View Profile



< Previous Page
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
Next Page >

© 2019 Stock News Now